Literature DB >> 10570189

Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells.

A R Karpf1, P W Peterson, J T Rawlins, B K Dalley, Q Yang, H Albertsen, D A Jones.   

Abstract

Inhibitors of DNA methyltransferase, typified by 5-aza-2'-deoxycytidine (5-Aza-CdR), induce the expression of genes transcriptionally down-regulated by de novo methylation in tumor cells. We utilized gene expression microarrays to examine the effects of 5-Aza-CdR treatment in HT29 colon adenocarcinoma cells. This analysis revealed the induction of a set of genes that implicated IFN signaling in the HT29 cellular response to 5-Aza-CdR. Subsequent investigations revealed that the induction of this gene set correlates with the induction of signal transducer and activator of transcription (STAT) 1, 2, and 3 genes and their activation by endogenous IFN-alpha. These observations implicate the induction of the IFN-response pathway as a major cellular response to 5-Aza-CdR and suggests that the expression of STATs 1, 2, and 3 can be regulated by DNA methylation. Consistent with STAT's limiting cell responsiveness to IFN, we found that 5-Aza-CdR treatment sensitized HT29 cells to growth inhibition by exogenous IFN-alpha2a, indicating that 5-Aza-CdR should be investigated as a potentiator of IFN responsiveness in certain IFN-resistant tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570189      PMCID: PMC24181          DOI: 10.1073/pnas.96.24.14007

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-gamma gene.

Authors:  H A Young; P Ghosh; J Ye; J Lederer; A Lichtman; J R Gerard; L Penix; C B Wilson; A J Melvin; M E McGurn
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

2.  A new imprinted gene cloned by a methylation-sensitive genome scanning method.

Authors:  I Hatada; T Sugama; T Mukai
Journal:  Nucleic Acids Res       Date:  1993-12-11       Impact factor: 16.971

3.  The genomic structure of the STAT genes: multiple exons in coincident sites in Stat1 and Stat2.

Authors:  R Yan; S Qureshi; Z Zhong; Z Wen; J E Darnell
Journal:  Nucleic Acids Res       Date:  1995-02-11       Impact factor: 16.971

4.  Isolation of DNA fragments associated with methylated CpG islands in human adenocarcinomas of the lung using a methylated DNA binding column and denaturing gradient gel electrophoresis.

Authors:  M Shiraishi; Y H Chuu; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells.

Authors:  Y L Ottaviano; J P Issa; F F Parl; H S Smith; S B Baylin; N E Davidson
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

6.  Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms.

Authors:  P Wang; P Wu; M I Siegel; R W Egan; M M Billah
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

7.  Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon.

Authors:  J P Issa; Y L Ottaviano; P Celano; S R Hamilton; N E Davidson; S B Baylin
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

8.  Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells.

Authors:  A D Luster; S C Jhanwar; R S Chaganti; J H Kersey; J V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

9.  Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation.

Authors:  R Jüttermann; E Li; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

10.  A new theory of carcinogenesis.

Authors:  R Holliday
Journal:  Br J Cancer       Date:  1979-10       Impact factor: 7.640

View more
  55 in total

Review 1.  The impact of the Cancer Genome Atlas on lung cancer.

Authors:  Jeremy T-H Chang; Yee Ming Lee; R Stephanie Huang
Journal:  Transl Res       Date:  2015-08-10       Impact factor: 7.012

2.  DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.

Authors:  David Roulois; Helen Loo Yau; Rajat Singhania; Yadong Wang; Arnavaz Danesh; Shu Yi Shen; Han Han; Gangning Liang; Peter A Jones; Trevor J Pugh; Catherine O'Brien; Daniel D De Carvalho
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

3.  Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

Authors:  Katherine B Chiappinelli; Pamela L Strissel; Alexis Desrichard; Huili Li; Christine Henke; Benjamin Akman; Alexander Hein; Neal S Rote; Leslie M Cope; Alexandra Snyder; Vladimir Makarov; Sadna Budhu; Sadna Buhu; Dennis J Slamon; Jedd D Wolchok; Drew M Pardoll; Matthias W Beckmann; Cynthia A Zahnow; Taha Merghoub; Taha Mergoub; Timothy A Chan; Stephen B Baylin; Reiner Strick
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

Review 4.  DNA Hypomethylating Drugs in Cancer Therapy.

Authors:  Takahiro Sato; Jean-Pierre J Issa; Patricia Kropf
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

Review 5.  Molecular epigenetics and genetics in neuro-oncology.

Authors:  Raman P Nagarajan; Joseph F Costello
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 6.  Combining Epigenetic and Immunotherapy to Combat Cancer.

Authors:  Katherine B Chiappinelli; Cynthia A Zahnow; Nita Ahuja; Stephen B Baylin
Journal:  Cancer Res       Date:  2016-03-17       Impact factor: 12.701

7.  Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review.

Authors:  Michal Chovanec; Fadi Taza; Maitri Kalra; Noah Hahn; Kenneth P Nephew; Michael J Spinella; Costantine Albany
Journal:  Target Oncol       Date:  2018-02       Impact factor: 4.493

8.  A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma.

Authors:  Xiaoming Yao; Ji-Fan Hu; Mark Daniels; Hadas Shiran; Xiangjun Zhou; Huifan Yan; Hongqi Lu; Zhilan Zeng; Qingxue Wang; Tao Li; Andrew R Hoffman
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 9.  Targeting the cancer epigenome for therapy.

Authors:  Peter A Jones; Jean-Pierre J Issa; Stephen Baylin
Journal:  Nat Rev Genet       Date:  2016-09-15       Impact factor: 53.242

10.  Differential expression of bikunin (HAI-2/PB), a proposed mediator of glioma invasion, by demethylation treatment.

Authors:  James M Schuster; Maria Longo; Peter S Nelson
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.